Loading company…
Theravia develops and promotes medicines for rare and debilitating conditions.
Founded in 2019 and based in Neuilly-sur-Seine, France, Theravia develops and promotes medical products for rare and debilitating conditions. Its products include Orphacol for bile acid synthesis disorders, Siklos for sickle cell disease, and Neofordex for multiple myeloma. In April 2025, Norgine B.V., a portfolio company of Goldman Sachs Asset Management, agreed to acquire the company from Mérieux Equity Partners; terms were not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in